Valproate and pregnancy
Sabers, A.
Ugeskrift for Laeger 173(10): 743
2011
ISSN/ISBN: 1603-6824 PMID: 21375998 Document Number: 651063
Document emailed within 1 workday
Related Documents
Bolaños, J.P.; Medina, J.M. 1993: Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain Molecular Pharmacology 43(3): 487-490Peckman, H. 2010: The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate North Carolina Medical Journal 71(4): 396-398
Chapman, A.G. 1986: Valproate and myoclonus Advances in Neurology 43: 661-674
Thygesen, K.S.øl.; Wolf, P. 2005: Valproate-caused encephalopathy Ugeskrift for Laeger 167(40): 3793-3794
Hoffman, L.M. 1982: Sodium valproate and thrombocytopenia Canadian Medical Association Journal 126(4): 358-359
Hamad, A.E.; Fawzi, M.E. 2000: Valproate associated acute pancreatitis Neurosciences 5(3): 156-158
Hess, C.W. 1994: 25 years of valproate in Switzerland Praxis 83(40): 1097
Minns, R.A.; Brown, J.K.; Blackwood, D.H.; McQueen, J.K. 1982: Valproate levels in children with epilepsy Lancet 1(8273): 677-678
Hernández, M.A.; Valencia, M.E.; Castillo, R.; Anciones, B. 1988: Sodium valproate in the treatment of choreoathetosis Medicina Clinica 90(12): 516
Barros, H.M.; Barros, E.J.; Carvalhaes, J.T. 1986: Acute pancreatitis associated with the use of sodium valproate Amb: Revista da Associacao Medica Brasileira 32(1-2): 33-34
Rzewuska, M.łg. 2002: Valproate in the treatment of bipolar disorder Psychiatria Polska 36(2): 239-257
Schmutz, M.; Olpe, H.R.; Koella, W.P. 1979: Central actions of valproate sodium Journal of Pharmacy and Pharmacology 31(6): 413-414
Miyamoto, T.; Miyamoto, M.; Hirata, K.; Katayama, S. 1999: A case report of valproate encephalopathy Rinsho Shinkeigaku 39(10): 1075-1077
VanValkenburg, C.; Kluznik, J.; Merrill, R.; Erickson, W. 1990: Therapeutic levels of valproate for psychosis Psychopharmacology Bulletin 26(2): 254-255
Gupta, A.K. 1988: 'Perming' effects associated with chronic valproate therapy British Journal of Clinical Practice 42(2): 75-77
Zhu, D.; Su, Z.; Ye, S.; Chen, X.; Zhuge, G.; Wu, Z. 2014: Clinical misdiagnosis analysis of valproate encephalopathy Zhonghua Yi Xue Za Zhi 94(33): 2610-2612
Leary, P.M.; Morris, S. 1980: Clinical experience with sodium valproate in children South African Medical Journal 57(21): 866-867
Young, P.; Finn, Bárbara.C.; Alvarez, F.; Bruetman, J.E.; Trimarchi, Hán. 2007: Valproate-associated hyperammonemic encephalopathy. Report of one case Revista Medica de Chile 135(11): 1446-1449
Berkovic, S.F.; Andermann, F.; Guberman, A.; Hipola, D.; Bladin, P.F. 1989: Valproate prevents the recurrence of absence status Neurology 39(10): 1294-1297
Deltito, J.A. 1994: Valproate pretreatment for the difficult-to-treat patient with OCD Journal of Clinical Psychiatry 55(11): 500